Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-FALD
NCT06324396Phase 1Recruiting
- Sponsor
- Children's Mercy Kansas City
- Start
- Mar 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ASP-001 and pravastatin, sponsored by Children's Mercy Kansas City. Primary endpoints: Sildenafil concentration as measured by area under the curve (AUC) at 2 years and Pravastatin concentration as measured by area under the curve (AUC) at 2 years. Started Mar 2024; status: recruiting.
02
Drugs
ASP-001pravastatin
Beyond the preview
Go deeper on NCT06324396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06324396.